• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短篇通讯:阿苯达唑在感染多房棘球绦虫的小鼠中的疗效取决于宿主的功能性免疫。

Short communication: Efficacy of albendazole in Echinococcus multilocularis-infected mice depends on the functional immunity of the host.

机构信息

Institute of Parasitology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Berne, Längassstrasse 122, 3012, Berne, Switzerland; Institute for Infectious Diseases, Faculty of Medicine, University of Berne, Friedbühlstrasse 51, 3010, Berne, Switzerland.

Institute of Parasitology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Berne, Längassstrasse 122, 3012, Berne, Switzerland.

出版信息

Exp Parasitol. 2020 Dec;219:108013. doi: 10.1016/j.exppara.2020.108013. Epub 2020 Oct 1.

DOI:10.1016/j.exppara.2020.108013
PMID:33010287
Abstract

Alveolar echinococcosis (AE) is a deadly parasitic disease that requires lifelong treatment with albendazole. Development of host immunity is pivotal with regard to the clinical outcome of AE, but its influence on conventional albendazole treatment is unknown. Using T-cell deficient athymic nude mice, we demonstrated that functional immunity is required for albendazole to be efficacious against murine AE. These results call for attention given the increasing number of immunocompromised patients with AE.

摘要

细粒棘球蚴病(AE)是一种致命的寄生虫病,需要终身用阿苯达唑治疗。宿主免疫的发展对于 AE 的临床结果至关重要,但它对常规阿苯达唑治疗的影响尚不清楚。我们使用 T 细胞缺陷的先天性无胸腺裸鼠证明了功能免疫对于阿苯达唑治疗小鼠 AE 的有效性是必需的。鉴于患有 AE 的免疫功能低下患者数量不断增加,这些结果值得关注。

相似文献

1
Short communication: Efficacy of albendazole in Echinococcus multilocularis-infected mice depends on the functional immunity of the host.短篇通讯:阿苯达唑在感染多房棘球绦虫的小鼠中的疗效取决于宿主的功能性免疫。
Exp Parasitol. 2020 Dec;219:108013. doi: 10.1016/j.exppara.2020.108013. Epub 2020 Oct 1.
2
Impact of Albendazole on Cytokine and Chemokine Response Profiles in -Inoculated Mice.阿苯达唑对感染小鼠细胞因子和趋化因子应答谱的影响。
Biomed Res Int. 2021 May 7;2021:6628814. doi: 10.1155/2021/6628814. eCollection 2021.
3
Molecular survival strategies of Echinococcus multilocularis in the murine host.多房棘球绦虫在小鼠宿主体内的分子生存策略
Parasitol Int. 2006;55 Suppl:S45-9. doi: 10.1016/j.parint.2005.11.006. Epub 2005 Dec 13.
4
Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model.激酶抑制剂尼洛替尼和依维莫司对肺泡型棘球蚴病的体外及小鼠模型评价
Exp Parasitol. 2018 May;188:65-72. doi: 10.1016/j.exppara.2018.04.002. Epub 2018 Apr 3.
5
Albendazole reduces hepatic inflammation and endoplasmic reticulum-stress in a mouse model of chronic Echinococcus multilocularis infection.阿苯达唑可减轻慢性泡状棘球蚴感染小鼠模型的肝炎症和内质网应激。
PLoS Negl Trop Dis. 2022 Jan 14;16(1):e0009192. doi: 10.1371/journal.pntd.0009192. eCollection 2022 Jan.
6
In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.基于甲氟喹的治疗方案对细粒棘球蚴病的体内外疗效。
Antimicrob Agents Chemother. 2011 Feb;55(2):713-21. doi: 10.1128/AAC.01392-10. Epub 2010 Dec 6.
7
Hints for control of infection in unique extrahepatic vertebral alveolar echinococcosis.独特型肝外脊柱肺泡型棘球蚴病的感染控制要点
Infection. 2017 Jun;45(3):365-368. doi: 10.1007/s15010-016-0974-z. Epub 2016 Dec 21.
8
Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.阿苯达唑联合百里酚对多房棘球绦虫原头节和中绦期幼虫的疗效。
Acta Trop. 2014 Dec;140:61-7. doi: 10.1016/j.actatropica.2014.08.007. Epub 2014 Aug 19.
9
In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes.单独或与阿苯达唑联合使用的2-甲氧基雌二醇对细粒棘球绦虫幼虫的体外和体内作用
Exp Parasitol. 2008 Aug;119(4):475-482. doi: 10.1016/j.exppara.2008.02.012. Epub 2008 Mar 7.
10
Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.基于阿苯达唑-壳聚糖微球的治疗对小鼠肺泡型棘球蚴病的疗效
PLoS Negl Trop Dis. 2015 Sep 9;9(9):e0003950. doi: 10.1371/journal.pntd.0003950. eCollection 2015.

引用本文的文献

1
Albendazole specifically disrupts microtubules and protein turnover in the tegument of the cestode Mesocestoides corti.阿苯达唑特异性地破坏绦虫中殖孔绦虫皮层中的微管和蛋白质周转。
PLoS Pathog. 2025 Jun 4;21(6):e1013221. doi: 10.1371/journal.ppat.1013221. eCollection 2025 Jun.
2
Chemotherapy for the treatment of alveolar echinococcosis: Where are we?化疗治疗泡型包虫病:我们处于什么阶段?
Parasite. 2024;31:56. doi: 10.1051/parasite/2024055. Epub 2024 Sep 23.
3
Characterization of protein cargo of Echinococcus granulosus extracellular vesicles in drug response and its influence on immune response.
棘球蚴细胞外囊泡中蛋白质货物的特性及其对免疫反应的影响与药物反应。
Parasit Vectors. 2023 Jul 29;16(1):255. doi: 10.1186/s13071-023-05854-6.
4
Response of wild rodents to red fox feces: implication for the echinococcus infection.野生啮齿动物对赤狐粪便的反应:对细粒棘球蚴感染的启示。
J Vet Med Sci. 2023 May 3;85(5):565-570. doi: 10.1292/jvms.22-0395. Epub 2023 Mar 29.
5
Albendazole reduces hepatic inflammation and endoplasmic reticulum-stress in a mouse model of chronic Echinococcus multilocularis infection.阿苯达唑可减轻慢性泡状棘球蚴感染小鼠模型的肝炎症和内质网应激。
PLoS Negl Trop Dis. 2022 Jan 14;16(1):e0009192. doi: 10.1371/journal.pntd.0009192. eCollection 2022 Jan.